PAAB DTC Services

The PAAB provides a user fee advisory service on direct to consumer (DTC) promotional activities regarding the treatment of disease with Federal Drug Schedule F and Schedule D biological drugs that would require a prescription for sale in Canada. The allowable activities are stated in the Health Canada policy "The Distinction Between Advertising and Other Activities" and that document is used as the basis for the review. The PAAB advisory review service is recognized and endorsed by Health Canada. PAAB maintains a liaison with Health Canada regarding the regulation of promotional activities for healthcare products.

The Health Canada policy "The Distinction Between Advertising and Other Activities" can be found at the following link:
http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/advert-publicit/actv_promo_vs_info-eng.pdf

Please see the PAAB Fee Schedule under "Resources" for the current advisory fees.

Current DTC activities reviewed by the PAAB are:

• Help-seeking Messages
• Consumer Brochures
• Consumer Websites
• Consumer Ad Campaigns
• Institutional Messages
• Brand Reminder ads
• Press Releases
• Clinical Trial Recruitment
• Physicians Websites